10412 Results
1

A potential new treatment for brain tumors

September 23, 2022

The University of Cincinnati's Pankaj Desai, PhD, has received a $1.19 million grant from the National Institutes of Health/National Institute of Neurological Disorders and Stroke to continue research into the use of a drug called letrozole to treat glioblastomas, the most deadly form of brain tumors.

2

Understanding breast cancer recurrence, metastatic spread

September 6, 2022

University of Cincinnati and Cincinnati Children's Hospital Medical Center researchers published new findings on metabolic signatures that help predict breast cancer outcomes and could open avenues for new treatments in the journal PLOS ONE.

4

Using light to restore cell function

August 2, 2022

The University of Cincinnati's Jiajie Diao, PhD, and colleagues have published new research in the journal Nature Communications showing light-activated proteins can help normalize dysfunction within cells.

5

New probe aids novel findings on cell functions

May 8, 2023

The University of Cincinnati's Jiajie Diao and Yujie Sun led recently published research showing the use of a new cellular probe helped discover new findings about certain cellular processes.

6

Unlocking how mutations help pancreatic cancer grow

January 10, 2023

Krushna Patra is the first University of Cincinnati researcher to receive the prestigious National Cancer Institute MERIT Award to continue his research on how mutations help pancreatic cancer grow.

7

NIH-funded UC research to study copper effects on kidney cancer

January 17, 2024

The University of Cincinnati Cancer Center’s Maria Czyzyk-Krzeska, MD, PhD, has been awarded a five-year, $2.8 million grant from the National Institutes of Health to investigate how copper contributes to the advancement and recurrence of clear cell renal cell carcinoma.

9

UC COVID-19 studies awarded $425K

April 15, 2020

Understanding that time was of the essence in combating this highly infectious disease, UC and its College of Medicine’s Office of Research conducted a rapid review and distribution of $425,000 in novel pilot grants to researchers, focusing on eradicating the disease.